Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

8.50
+0.04000.47%
Volume:12.23K
Turnover:103.29K
Market Cap:14.88M
PE:-0.32
High:8.76
Open:8.48
Low:8.05
Close:8.46
52wk High:49.60
52wk Low:3.02
Shares:1.75M
Float Shares:694.50K
Volume Ratio:0.38
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-26.9141
EPS(LYR):-20.5537
ROE:-155.28%
ROA:-17.97%
PB:1.03
PE(LYR):-0.41

Loading ...

Jul 02, 2026

Major Issues Report

Form 8-K - Current report
Jun 26, 2026

Major Issues Report

Form 8-K - Current report
Jun 26, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 30, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Jan 28, 2026

Correspondence

Form CORRESP - Correspondence
Jan 23, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2025

Correspondence

Form CORRESP - Correspondence
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 23, 2025

Major Issues Report

Form 8-K - Current report